leventa
schering-plough animal health limited - levothyroxine sodium pentahydrate - levothyroxine sodium pentahydrate 1 g/litre - endocrine agent (hormone)
posatex
schering-plough animal health limited - mometasone furoate monohydrate; posaconazole; orbifloxacin - mometasone furoate monohydrate 1 g/kg; posaconazole 1 g/kg; orbifloxacin 10 g/kg - antibiotic
activyl
schering-plough animal health limited - indoxacarb - indoxacarb 195 g/litre - ectoparasiticide
multine b12
schering-plough animal health limited - clostridium perfringens type d toxoid; clostridium tetani toxoid; clostridium septicum toxoid; clostridium chauvoei toxoid/cells; hydroxocobalamin acetate; clostridium novyi type b toxoid/cells - clostridium perfringens type d toxoid 0 vaccine; clostridium tetani toxoid 0 vaccine; clostridium septicum toxoid 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine; hydroxocobalamin acetate 1 g/litre; clostridium novyi type b toxoid/cells 0 vaccine - parenteral nutrient/electrolyte
porcilis pcv m hyo
schering-plough animal health limited - mycoplasma hyopneumoniae; porcine circovirus type 2 orf-2 protein - mycoplasma hyopneumoniae 0 vaccine; porcine circovirus type 2 orf-2 protein 0 vaccine - vaccine
bravecto plus
schering-plough animal health limited - fluralaner; moxidectin - fluralaner 280 g/litre; moxidectin 14 g/litre - endoparasiticide
avelox- moxifloxacin hydrochloride injection, solution avelox- moxifloxacin hydrochloride tablet, film coated
schering plough corporation - moxifloxacin hydrochloride (unii: c53598599t) (moxifloxacin - unii:u188xyd42p) - moxifloxacin 400 mg in 250 ml - avelox is indicated in adult patients for the treatment of community acquired pneumonia caused by susceptible isolates of streptococcus pneumoniae (including multi-drug resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, moraxella catarrhalis, methicillin-susceptible staphylococcus aureus, klebsiella pneumoniae, mycoplasma pneumoniae, or chlamydophila pneumoniae [see clinical studies (14.3 )] . mdrsp isolates are isolates resistant to two or more of the following antibacterial drugs: penicillin (minimum inhibitory concentrations [mic] ≥ 2 mcg/ml), 2nd generation cephalosporins (for example, cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole. avelox is indicated in adult patients for the treatment of uncomplicated skin and skin structure infections caused by susceptible isolates of methicillin-susceptible staphylococcus aureus or streptococcus pyogenes [see clinical studies (14.4 )]. avelox is indicated in adult patients for the treatment of complicated skin and ski
exzolt
schering-plough animal health limited - fluralaner - fluralaner 10 g/litre - ectoparasiticide
bovilis mh + ibr
schering-plough animal health limited - infectious bovine rhinotrocheitis virus (inactivated); pasteurella haemolytica (inactivated); pasteurella haemolytica (inactivated) - infectious bovine rhinotrocheitis virus (inactivated) 0 vaccine; pasteurella haemolytica (inactivated) 0 vaccine; pasteurella haemolytica (inactivated) 0 vaccine - vaccine
vidalta 15
schering-plough animal health limited - carbimazole - carbimazole 150 g/kg - endocrine agent (hormone)